Zoledronic Acid for prevention of bone and muscle loss after BAriatric Surgery (ZABAS)-a study protocol for a randomized controlled trial
Abstract Background Bariatric surgery has adverse effects on the muscular-skeletal system with loss of bone mass and muscle mass and an increase in the risk of fracture. Zoledronic acid is widely used in osteoporosis and prevents bone loss and fracture. Bisphosphonates may also have positive effects...
Main Authors: | Søren Gam, Bibi Gram, Claus Bogh Juhl, Anne Pernille Hermann, Stinus Gadegaard Hansen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-10-01
|
Series: | Trials |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13063-022-06766-z |
Similar Items
-
Bariatric Surgery Reduces Weight Loss, Comorbidities Prevalence, and Improves Quality of Life in the Southern Region of Saudi Arabia
by: Abdulaziz A. Arishi, et al.
Published: (2023-09-01) -
Development of bariatric/metabolic surgery in Vojvodina
by: Putnik Srđan S., et al.
Published: (2022-01-01) -
Comment: pregnancy after bariatric surgery – achievements and open questions
by: Christian S. Göbl, et al.
Published: (2023-08-01) -
Does Postoperative Oral and Intestinal Microbiota Correlate with the Weight-Loss Following Bariatric Surgery?—A Cohort Study
by: Tomasz Stefura, et al.
Published: (2020-11-01) -
Total weight loss induces the alteration in thyroid function after bariatric surgery
by: Ziru Tian, et al.
Published: (2024-01-01)